Report Pursuant to Section 28a of the Danish Securities Trading Act
February 24, 2016 12:58 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; February 24, 2016 – In accordance with Section 28a of the Danish Securities Trading Act, the company’s board members and executives have given Genmab A/S...
Kapitalforhøjelse i Genmab som følge af udnyttelse af medarbejderwarrants
February 24, 2016 12:52 ET
|
Genmab A/S
Selskabsmeddelelse
København, Danmark, 24. februar 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) forhøjer selskabets aktiekapital med 146.321 aktier som følge af udnyttelse af...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
February 24, 2016 12:52 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; February 24, 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 146,321 shares as a consequence of the exercise of employee...
Indkaldelse til ordinær generalforsamling i Genmab A/S
February 23, 2016 02:11 ET
|
Genmab A/S
Selskabsmeddelelse
Genmab A/S afholder generalforsamling den 17. marts 2016
København, Danmark, 23. februar 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) afholder ordinær generalforsamling...
Genmab A/S Summons Annual General Meeting
February 23, 2016 02:11 ET
|
Genmab A/S
Company Announcement
Genmab A/S to hold Annual General Meeting on March 17, 2016
Copenhagen, Denmark; February 23, 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) summons the Annual General...
Genmab 2015 Annual Report
February 17, 2016 11:01 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; February 17, 2016 – Genmab A/S (OMX: GEN) announced today its Annual Report for 2015. Below is a summary of business progress and financial...
Genmab 2015 Annual Report
February 17, 2016 11:01 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; February 17, 2016 – Genmab A/S (OMX: GEN) announced today its Annual Report for 2015. Below is a summary of business progress and financial...
Major Shareholder Announcement
February 04, 2016 17:30 ET
|
Genmab A/S
Company Announcement
Major shareholder announcement for Genmab A/S
Copenhagen, Denmark; February 4, 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the...
Storaktionærmeddelelse
February 04, 2016 17:30 ET
|
Genmab A/S
Selskabsmeddelelse
Storaktionærmeddelelse for Genmab A/S
København, Danmark, 4. februar 2016 – Genmab A/S (Nasdaq Copenhagen: GEN) skal under henvisning til Værdipapirlovens paragraf 29...
Genmab Announces U.S. FDA Approval of Arzerra® (ofatumumab) as Extended Treatment for Recurrent or Progressive CLL
January 19, 2016 15:15 ET
|
Genmab A/S
Company Announcement
Arzerra now approved by U.S. FDA for use for extended treatment of patients with recurrent or progressive CLL
Approval based on data from interim analysis of Phase III...